XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Accumulated foreign currency adjustment attributable to parent
Accumulated defined benefit plans adjustment attributable to parent
Accumulated other comprehensive (loss) income
Treasury stock
Balance at the beginning of the year at Dec. 31, 2020   $ 2,676 $ 921,752 $ 7,094,656 $ (250,748) $ (253,720)   $ (1,565,270)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   10            
Issuance of common stock under employee stock plans     29,544         7,309
Share-based compensation expense     35,021          
Net income $ 708,372     708,372        
Cash dividends paid       (138,345)        
Other       (1)        
Translation adjustments         (45,160)      
Change in long-term intercompany notes         (11,041)      
Net investment hedge instruments gain (loss), net of tax of $(14,604) and $(5,715) for the quarter ended September 30, 2022 and 2021, and $(34,212) and $(10,194) for the nine months ended September 30, 2022 and 2021, respectively         31,514      
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended September 30, 2022 and 2021, and $(977) and $(1,581) for the nine months ended September 30, 2022 and 2021, respectively           4,890    
Purchase of treasury stock               (13,063)
Balance at the end of the year at Sep. 30, 2021 6,558,396 2,686 986,317 7,664,682 (275,435) (248,830) $ (524,265) (1,571,024)
Balance at the beginning of the year at Jun. 30, 2021   2,684 964,791 7,453,401 (256,421) (250,460)   (1,570,696)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   2            
Issuance of common stock under employee stock plans     10,098         (143)
Share-based compensation expense     11,428          
Net income 257,460     257,460        
Cash dividends paid       (46,178)        
Other       (1)        
Translation adjustments         (31,207)      
Change in long-term intercompany notes         (5,475)      
Net investment hedge instruments gain (loss), net of tax of $(14,604) and $(5,715) for the quarter ended September 30, 2022 and 2021, and $(34,212) and $(10,194) for the nine months ended September 30, 2022 and 2021, respectively         17,668      
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended September 30, 2022 and 2021, and $(977) and $(1,581) for the nine months ended September 30, 2022 and 2021, respectively           1,630    
Purchase of treasury stock               (185)
Balance at the end of the year at Sep. 30, 2021 6,558,396 2,686 986,317 7,664,682 (275,435) (248,830) (524,265) (1,571,024)
Balance at the beginning of the year at Dec. 31, 2021 6,871,884 2,689 1,012,526 7,900,113 (275,365) (195,079)   (1,573,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   6            
Issuance of common stock under employee stock plans     11,966         2,387
Share-based compensation expense     34,587          
Net income 852,461     852,461        
Cash dividends paid       (151,635)        
Other       (1)        
Translation adjustments         (225,100)      
Change in long-term intercompany notes         (40,512)      
Net investment hedge instruments gain (loss), net of tax of $(14,604) and $(5,715) for the quarter ended September 30, 2022 and 2021, and $(34,212) and $(10,194) for the nine months ended September 30, 2022 and 2021, respectively         105,053      
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended September 30, 2022 and 2021, and $(977) and $(1,581) for the nine months ended September 30, 2022 and 2021, respectively           3,000    
Purchase of treasury stock               (331,424)
Balance at the end of the year at Sep. 30, 2022 7,132,672 2,695 1,059,079 8,600,938 (435,924) (192,079) (628,003) (1,902,037)
Balance at the beginning of the year at Jun. 30, 2022   2,695 1,040,951 8,353,735 (352,851) (193,079)   (1,901,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   0            
Issuance of common stock under employee stock plans     6,068         (632)
Share-based compensation expense     12,060          
Net income 297,641     297,641        
Cash dividends paid       (50,438)        
Other       0        
Translation adjustments         (110,524)      
Change in long-term intercompany notes         (17,393)      
Net investment hedge instruments gain (loss), net of tax of $(14,604) and $(5,715) for the quarter ended September 30, 2022 and 2021, and $(34,212) and $(10,194) for the nine months ended September 30, 2022 and 2021, respectively         44,844      
Amortization of net actuarial loss and other, net of tax of $(326) and $(527) for the quarter ended September 30, 2022 and 2021, and $(977) and $(1,581) for the nine months ended September 30, 2022 and 2021, respectively           1,000    
Purchase of treasury stock               (45)
Balance at the end of the year at Sep. 30, 2022 $ 7,132,672 $ 2,695 $ 1,059,079 $ 8,600,938 $ (435,924) $ (192,079) $ (628,003) $ (1,902,037)